<DOC>
	<DOC>NCT00532506</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical efficacy and safety of SK-0403 in patients with Type2 Diabetes Mellitus</brief_summary>
	<brief_title>Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Treatmentnaive subjects diagnosed with type 2 diabetes mellitus Stable diet program for at least 8 weeks Criteria for HbA1c are met Type 1 diabetes Patients treated with other antidiabetic drugs or Insulin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>